Literature DB >> 17706717

The role of preoperative testing on outcomes after sling surgery for stress urinary incontinence.

Jennifer T Anger1, Larissa V Rodríguez, Qin Wang, Chris L Pashos, Mark S Litwin.   

Abstract

PURPOSE: In this study we analyzed Medicare claims data to measure the effect of preoperative urodynamics and cystoscopy on outcomes after sling surgery.
MATERIALS AND METHODS: We analyzed 1999 to 2001 Medicare claims data on a 5% national random sample of beneficiaries. Women who underwent sling procedures between July 1, 1999 and December 31, 2000 were identified on the basis of the presence of CPT-4 code 57288 (sling operation for stress incontinence). Subjects were tracked for 6 months before surgery to identify type of preoperative studies performed (urodynamics and cystoscopy) and for 12 months after surgery to assess short-term complications.
RESULTS: Of 1,356 subjects 24.8% underwent preoperative cystoscopy and 27.4% underwent preoperative urodynamic testing. In postoperative year 1, 32.4% of subjects underwent cystoscopy and 30.5% underwent urodynamics. Patients who underwent preoperative urodynamics were more likely to be newly diagnosed with urge incontinence after surgery (21.9% vs 12.7%, p <0.0001). Those who underwent preoperative cystoscopy were significantly more likely to be diagnosed with (9.4% vs 6.1%, p <0.043) or treated for (10.6% vs 7.2%, p <0.047) outlet obstruction postoperatively than those who did not. Multivariate analysis revealed that subjects who underwent preoperative urodynamics were significantly less likely to undergo postoperative urodynamics than those who did not (OR 0.34, 95% CI 0.24-0.48).
CONCLUSIONS: Our findings of worse outcomes among women who underwent preoperative testing may be due in part to case selection. Our finding that women who underwent preoperative urodynamics were only a third as likely to undergo postoperative urodynamics as those who did not supports the use of urodynamics in the preoperative setting. However, the true effect of urodynamics on sling outcomes remains controversial.

Entities:  

Mesh:

Year:  2007        PMID: 17706717     DOI: 10.1016/j.juro.2007.05.139

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  The Quality of Care Provided to Women with Urinary Incontinence in 2 Clinical Settings.

Authors:  Jennifer T Anger; Alexandriah Alas; Mark S Litwin; Stephanie D Chu; Catherine Bresee; Carol P Roth; Rezoana Rashid; Paul Shekelle; Neil S Wenger
Journal:  J Urol       Date:  2016-05-07       Impact factor: 7.450

2.  Overactive bladder after sling surgery.

Authors:  Kamran P Sajadi; Sandip P Vasavada
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

3.  The cost of preoperative urodynamics: A secondary analysis of the ValUE trial.

Authors:  Peggy A Norton; Charles W Nager; Linda Brubaker; Gary E Lemack; Larry T Sirls; Robert Holley; Toby C Chai; Stephen R Kraus; Halina Zyczynski; Bridget Smith; Anne Stoddard
Journal:  Neurourol Urodyn       Date:  2014-10-18       Impact factor: 2.696

Review 4.  Safety considerations for synthetic sling surgery.

Authors:  Jerry G Blaivas; Rajveer S Purohit; Matthew S Benedon; Gabriel Mekel; Michael Stern; Mubashir Billah; Kola Olugbade; Robert Bendavid; Vladimir Iakovlev
Journal:  Nat Rev Urol       Date:  2015-08-18       Impact factor: 14.432

5.  Patterns and predictors of urodynamics use in the United States.

Authors:  W Stuart Reynolds; Roger R Dmochowski; Julie Lai; Chris Saigal; David F Penson
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

6.  Assessing professional equipoise and views about a future clinical trial of invasive urodynamics prior to surgery for stress urinary incontinence in women: a survey within a mixed methods feasibility study.

Authors:  Paul Hilton; Andy Bryant; Denise Howel; Elaine McColl; Brian S Buckley; Malcolm Lucas; Douglas G Tincello; Natalie Armstrong
Journal:  Neurourol Urodyn       Date:  2012-09-28       Impact factor: 2.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.